CompletedPhase 2NCT00484679

Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Minnesota
Principal Investigator
Maria K Hordinsky, MD
University of Minnesota
Intervention
Triamcinolone Acetonide 10 mg/mL (Kenalog-10)(drug)
Enrollment
18 target
Eligibility
18 years · All sexes
Timeline
20072011

Study locations (1)

Collaborators

National Alopecia Areata Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00484679 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials